Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    ARNA

Delayed Quote. Delayed  - 09/26 07:04:38 pm
1.76 USD   +1.15%
09/01 ARENA PHARMACEU : Pharmaceutics Announces Formation of Beacon Discov..
08/30 INNOVUS PHARMAC : Pharma Appoints Robert Hoffman As EVP And CFO
08/15 ARENA PHARMACEU : Announces Appointment of Vincent Aurentz as Chief ..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector news 
Most relevant news about ARENA PHARMACEUTICALS, INC
09/01 ARENA PHARMACEUTICALS : Pharmaceutics Announces Formation of Beacon Discovery
08/30 INNOVUS PHARMACEUTICALS : Pharma Appoints Robert Hoffman As EVP And CFO
08/15 ARENA PHARMACEUTICALS : Announces Appointment of Vincent Aurentz as Chief Busine..
08/08 ARENA PHARMACEUTICALS : reports 2Q loss
08/08 ARENA PHARMACEUTICALS : Reports Second Quarter 2016 Financial Results and Provid..
08/04 STOCKS WITHIN TRADERS RADAR : Community Health Systems, Inc. Arena Pharmaceutic..
08/01 ARENA PHARMACEUTICALS : to Release Second Quarter 2016 Financial Results and Pro..
07/27 ARENA PHARMACEUTICALS : Eisai Inc. and Arena Pharmaceuticals Announce FDA Approv..
07/19 EISAI : Inc. and Arena Pharmaceuticals Announce FDA Approval of BELVIQ XR® (lorc..
07/14 ARENA PHARMACEUTICALS : Eisai and Arena Pharmaceuticals Announce Regulatory Appr..
06/30 ARENA PHARMACEUTICALS : Announces Shift to Focus on Proprietary Clinical Stage P..
06/16 ARENA PHARMACEUTICALS : Announces Appointment of Kevin R. Lind as Chief Financia..
06/15 ARENA PHARMACEUTICALS : Announces Appointment of Kevin R. Lind as Chief Financia..
06/13 ARENA PHARMACEUTICALS : Announces USAN Approval of Nonproprietary Name "Etrasimo..
05/09 ARENA PHARMACEUTICALS : reports 1Q loss
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
09/09 ARENA PHARMACEUTICALS : Pharmaceutics Announces Formation of Beacon Discovery
09/01 ARENA PHARMACEUTICALS INC : Change in Directors or Principal Officers, Other Eve..
09/01 ARENA PHARMACEUTICALS : Pharmaceutics Announces Formation of Beacon Discovery
08/30 INNOVUS PHARMACEUTICALS : Pharma Appoints Robert Hoffman As EVP And CFO
08/25 ARENA PHARMACEUTICALS INC : Other Events (form 8-K)
08/18 ARENA PHARMACEUTICALS : Reports Second Quarter 2016 Financial Results and Provid..
08/15 ARENA PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)
08/15 ARENA PHARMACEUTICALS : Announces Appointment of Vincent Aurentz as Chief Busine..
08/09 ARENA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condit..
08/08 ARENA PHARMACEUTICALS : reports 2Q loss
More news
Sector news : Biotechnology & Medical Research - NEC
04:45pDJPfizer Throws Out Plan to Split Into Two Companies
07:49aDJSANOFI : FDA Accepts Sanofi's, Regeneron's Dermatitis Treatment for Priority Rev..
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira
09/21DJGILEAD SCIENCES : Halts Test of Bowel Disease Treatment
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
09/07 Arena Co-Founder Steps Down To Run Research Company Contracting With Arena
09/01 Orexigen Inks Contrave Deal For Canada - Why Street Reaction Is Muted
08/26 ZAFGEN : Too Cheap To Ignore
08/10 ARENA : New Direction After $27 Million Loss?
08/08 Arena Pharmaceuticals' (ARNA) CEO Amit Munshi on Q2 2016 Results - Earnings C..
08/08 Arena Pharmaceuticals misses by $0.01, misses on revenue


Advertisement
Financials ($)
Sales 2016 46,2 M
EBIT 2016 -76,9 M
Net income 2016 -84,5 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 9,17x
Capi. / Sales 2017 9,31x
Capitalization 423 M
More Financials
Chart ARENA PHARMACEUTICALS, INC
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | ARNA | US0400471027 | 4-Traders
Full-screen chart
Technical analysis trends ARENA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 4,50 $
Spread / Average Target 159%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Amit D. Munshi President, Chief Executive Officer & Director
Craig M. Audet SVP-Operations & Head-Global Regulatory Affairs
Kevin R. Lind Chief Financial Officer & Executive Vice President
Donald D. Belcher Independent Director
Tina Susan Nova Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ARENA PHARMACEUTICALS,..-8.42%423
INCYTE CORPORATION-17.95%16 728
CELLTRION, INC.--.--%11 664
LONZA GROUP AG13.18%10 059
QUINTILES TRANSNATIONA..15.66%9 453
SEATTLE GENETICS, INC.24.40%7 845
More Results